Molecular biomarkers in multiple sclerosis.

Tjalf Ziemssen1, Katja Akgün2, Wolfgang Brück3

  • 1MS center, Center of Clinical Neuroscience, University Clinic Carl-Gustav Carus, Dresden University of Technology, Dresden, Germany. Tjalf.Ziemssen@uniklinikum-dresden.de.

Summary

Multiple sclerosis biomarkers are crucial for personalized patient care. This review highlights ideal molecular biomarker characteristics and promising blood/CSF markers for MS diagnosis, prognosis, and treatment monitoring.

Related Concept Videos